Literature DB >> 22707044

An overview of infectious bursal disease.

Hebata Allah Mahgoub1, Michael Bailey, Pete Kaiser.   

Abstract

Infectious bursal disease (IBD) is a viral immunosuppressive disease of chickens attacking mainly an important lymphoid organ in birds [the bursa of Fabricius (BF)]. The emergence of new variant strains of the causative agent [infectious bursal disease virus (IBDV)] has made it more urgent to develop new vaccination strategies against IBD. One of these strategies is the use of recombinant vaccines (DNA and viral-vectored vaccines). Several studies have investigated the host immune response towards IBDV. This review will present a detailed background on the disease and its causative agent, accompanied by a summary of the most recent findings regarding the host immune response to IBDV infection and the use of recombinant vaccines against IBD.

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22707044     DOI： 10.1007/s00705-012-1377-9

Source DB:  PubMed          Journal:  Arch Virol        ISSN： 0304-8608            Impact factor:   2.574


  40 in total

1.  Recombinant canarypox virus expressing the VP2 protein of infectious bursal disease virus induces protection in vaccinated SPF chickens.

Authors:  Flavia Adriana Zanetti; Romina Cardona; Carlos Rodolfo Federico; Silvina Chimeno-Zoth; Gabriela Calamante
Journal:  Virol Sin       Date:  2016-06       Impact factor: 4.327

2.  Infectious bursal disease: outbreak investigation, molecular characterization, and vaccine immunogenicity trial in Ethiopia.

Authors:  Aregitu Mekuriaw; Molalegne Bitew; Esyas Gelaye; Bedaso Mamo; Gelagay Ayelet
Journal:  Trop Anim Health Prod       Date:  2017-06-15       Impact factor: 1.559

3.  Risk factors associated with infectious bursal disease vaccination failures in broiler farms in Kenya.

Authors:  Wanzila Usyu Mutinda; Philip Njeru Nyaga; Paul Gichohi Mbuthia; Lilly Caroline Bebora; Gerald Muchemi
Journal:  Trop Anim Health Prod       Date:  2014-01-12       Impact factor: 1.559

4.  Atrophy of the lymphoid organs and suppression of antibody response caused by velogenic Newcastle disease virus infection in chickens.

Authors:  Wilfred Sunday Ezema; Didacus Chukwuemeka Eze; Shodeinde Vincent Olu Shoyinka; John Osita Arinze Okoye
Journal:  Trop Anim Health Prod       Date:  2016-09-19       Impact factor: 1.559

Review 5.  Advances on Innate Immune Evasion by Avian Immunosuppressive Viruses.

Authors:  Hongnuan Wang; Wei Li; Shijun J Zheng
Journal:  Front Immunol       Date:  2022-05-12       Impact factor: 8.786

6.  Exacerbated Apoptosis of Cells Infected with Infectious Bursal Disease Virus upon Exposure to Interferon Alpha.

Authors:  Liliana L Cubas-Gaona; Elisabet Diaz-Beneitez; Marina Ciscar; José F Rodríguez; Dolores Rodríguez
Journal:  J Virol       Date:  2018-05-14       Impact factor: 5.103

7.  Molecular characterization and phylogenetic analysis of infectious bursal disease viruses isolated from chicken in South China in 2011.

Authors:  Di Liu; Xiang-Bin Zhang; Zhuan-Qiang Yan; Feng Chen; Jun Ji; Jian-Ping Qin; Hai-Yan Li; Jun-Peng Lu; Yu Xue; Jia-Jia Liu; Qing-Mei Xie; Jing-Yun Ma; Chun-Yi Xue; Ying-Zuo Bee
Journal:  Trop Anim Health Prod       Date:  2012-12-02       Impact factor: 1.559

8.  Overexpression of recombinant infectious bursal disease virus (IBDV) capsid protein VP2 in the middle silk gland of transgenic silkworm.

Authors:  Hanfu Xu; Lin Yuan; Feng Wang; Yuancheng Wang; Riyuan Wang; Chunnuan Song; Qingyou Xia; Ping Zhao
Journal:  Transgenic Res       Date:  2014-08-09       Impact factor: 2.788

Review 9.  Reassortment in segmented RNA viruses: mechanisms and outcomes.

Authors:  Sarah M McDonald; Martha I Nelson; Paul E Turner; John T Patton
Journal:  Nat Rev Microbiol       Date:  2016-05-23       Impact factor: 60.633

Review 10.  Immunoglobulin Y for Potential Diagnostic and Therapeutic Applications in Infectious Diseases.

Authors:  Lucia Lee; Kate Samardzic; Michael Wallach; Lyn R Frumkin; Daria Mochly-Rosen
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.